Aemetis (AMTX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

AMTX Stock Forecast

Aemetis stock forecast is as follows: an average price target of $3.88 (represents a -6.05% downside from AMTX’s last price of $4.13) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.

AMTX Price Target

The average price target for Aemetis (AMTX) is $3.88 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $4.25 to $3.50. This represents a potential -6.05% downside from AMTX's last price of $4.13.

AMTX Analyst Ratings

Buy

According to 9 Wall Street analysts, Aemetis's rating consensus is 'Buy'. The analyst rating breakdown for AMTX stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 1 'Hold' (11.11%), 2 'Sell' (22.22%), and 0 'Strong Sell' (0.00%).

Aemetis Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jul 30, 2024	Jirdan Levy	Truist Financial	$3.50	$3.42	2.34%	-15.25%
May 13, 2024	Jordan Levy	Truist Financial	$4.00	$4.06	-1.48%	-3.15%
Feb 01, 2023	-	Truist Financial	$5.00	$4.67	7.07%	21.07%
Dec 14, 2022	-	UBS	$4.25	$4.43	-4.06%	2.91%
Aug 08, 2022	Jordan Levy	Truist Financial	$12.00	$11.12	7.91%	190.56%

Row per page

Go to

The latest Aemetis stock forecast, released on Jul 30, 2024 by Jirdan Levy from Truist Financial, set a price target of $3.50, which represents a 2.34% increase from the stock price at the time of the forecast ($3.42), and a -15.25% decrease from AMTX last price ($4.13).

Aemetis Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	2
Avg Price Target	-	-	$3.75
Last Closing Price	$4.13	$4.13	$4.13
Upside/Downside	-100.00%	-100.00%	-9.20%

In the current month, the average price target of Aemetis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aemetis's last price of $4.13. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 16, 2023	Keefe, Bruyette & Woods	-	Market Perform	Downgrade
Aug 16, 2023	Wolfe Research	-	Peer Perform	Downgrade
Aug 16, 2023	Argus Research	-	Sell	Downgrade
Aug 16, 2023	BTIG	-	Sell	Downgrade
Aug 16, 2023	UBS	Neutral	Buy	Upgrade
Aug 16, 2023	Citigroup	-	Overweight	Upgrade
Aug 16, 2023	Evercore ISI	-	Outperform	Upgrade
Aug 16, 2023	Benchmark	-	Speculative Buy	Upgrade
Aug 16, 2023	BMO Capital	-	Outperform	Upgrade
Dec 14, 2022	UBS	-	Neutral	Initialise

Row per page

Go to

Aemetis's last stock rating was published by Keefe, Bruyette & Woods on Aug 16, 2023. The company Downgrade its AMTX rating from "null" to "Market Perform".

Aemetis Financial Forecast

Aemetis Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$70.76M	$68.69M	$45.11M	$2.15M	$66.73M	$71.83M	$65.90M	$52.05M	$64.36M	$49.90M	$54.88M	$42.81M	$37.33M	$40.92M	$47.82M	$39.48M	$52.10M	$57.39M
Avg Forecast	$211.87M	$201.28M	$180.02M	$177.79M	$121.20M	$106.40M	$91.52M	$90.63M	$84.00M	$76.41M	$73.81M	$77.22M	$74.65M	$75.50M	$51.37M	$59.52M	$71.45M	$67.40M	$59.23M	$56.70M	$56.99M	$54.26M	$54.27M	$49.04M	$48.93M	$59.70M	$48.70M	$50.40M	$46.80M	$48.00M
High Forecast	$211.87M	$201.28M	$180.02M	$177.79M	$121.20M	$106.40M	$91.52M	$90.63M	$84.00M	$85.06M	$73.82M	$77.22M	$98.81M	$75.52M	$51.37M	$59.52M	$71.45M	$67.40M	$59.23M	$56.70M	$56.99M	$54.26M	$54.27M	$49.04M	$48.93M	$59.70M	$48.70M	$50.40M	$46.80M	$48.00M
Low Forecast	$211.87M	$201.28M	$180.02M	$177.79M	$121.20M	$106.40M	$91.52M	$90.63M	$84.00M	$69.50M	$73.80M	$77.22M	$52.49M	$75.48M	$51.37M	$59.52M	$71.45M	$67.40M	$59.23M	$56.70M	$56.99M	$54.26M	$54.27M	$49.04M	$48.93M	$59.70M	$48.70M	$50.40M	$46.80M	$48.00M
# Analysts	2	2	2	2	1	1	1	1	2	4	2	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	5	5
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.95%	0.91%	0.88%	0.04%	0.93%	1.07%	1.11%	0.92%	1.13%	0.92%	1.01%	0.87%	0.76%	0.69%	0.98%	0.78%	1.11%	1.20%

Aemetis's average Quarter revenue forecast for Mar 24 based on 4 analysts is $77.22M, with a low forecast of $77.22M, and a high forecast of $77.22M. AMTX's average Quarter revenue forecast represents a 9.12% increase compared to the company's last Quarter revenue of $70.76M (Dec 23).

Aemetis EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	1	2	4	2	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	5	5
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-7.20M	$-8.53M	$-7.79M	$-14.02M	$-8.65M	$-9.23M	$4.83M	$-12.21M	$5.36M	$-9.65M	$-1.97M	$-8.80M	$-7.33M	$-3.39M	$10.26M	$-4.61M	$844.00K	$-126.00K
Avg Forecast	$-15.80M	$-15.01M	$-13.43M	$-13.26M	$-9.04M	$-7.94M	$-6.83M	$-6.76M	$-6.26M	$-5.70M	$-5.50M	$-5.76M	$-5.57M	$-5.63M	$-3.83M	$-4.44M	$-5.33M	$-5.03M	$-4.42M	$-7.69M	$-4.25M	$-4.05M	$-4.05M	$-7.50M	$-3.65M	$-4.45M	$-3.63M	$-2.89M	$-3.49M	$-3.58M
High Forecast	$-15.80M	$-15.01M	$-13.43M	$-13.26M	$-9.04M	$-7.94M	$-6.83M	$-6.76M	$-6.26M	$-5.18M	$-5.50M	$-5.76M	$-3.91M	$-5.63M	$-3.83M	$-4.44M	$-5.33M	$-5.03M	$-4.42M	$-6.16M	$-4.25M	$-4.05M	$-4.05M	$-6.00M	$-3.65M	$-4.45M	$-3.63M	$-2.31M	$-3.49M	$-3.58M
Low Forecast	$-15.80M	$-15.01M	$-13.43M	$-13.26M	$-9.04M	$-7.94M	$-6.83M	$-6.76M	$-6.26M	$-6.34M	$-5.51M	$-5.76M	$-7.37M	$-5.63M	$-3.83M	$-4.44M	$-5.33M	$-5.03M	$-4.42M	$-9.23M	$-4.25M	$-4.05M	$-4.05M	$-9.00M	$-3.65M	$-4.45M	$-3.63M	$-3.47M	$-3.49M	$-3.58M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.29%	1.51%	2.03%	3.16%	1.62%	1.84%	-1.09%	1.59%	-1.26%	2.39%	0.49%	1.17%	2.01%	0.76%	-2.82%	1.60%	-0.24%	0.04%

3 analysts predict AMTX's average Quarter EBITDA for Sep 22 to be $-5.03M, with a high of $-5.03M and a low of $-5.03M. This is -204.12% lower than Aemetis's previous annual EBITDA (Jun 22) of $4.83M.

Aemetis Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	1	2	4	2	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	5	5
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-25.44M	$30.71M	$-25.28M	$-26.41M	$-22.41M	$-69.84M	$-209.00K	$-18.29M	$-881.00K	$-17.60M	$-10.56M	$-18.11M	$-14.58M	$-12.22M	$2.19M	$-12.05M	$-7.65M	$-6.33M
Avg Forecast	$2.31M	$3.91M	$795.26K	$-118.46K	$-6.23M	$-7.19M	$-10.47M	$-12.43M	$-16.66M	$-18.08M	$-20.53M	$-21.71M	$-18.20M	$-14.26M	$-15.52M	$-19.82M	$-14.28M	$-14.14M	$-12.98M	$-11.26M	$-11.78M	$-15.19M	$-15.71M	$-12.64M	$-23.54M	$-2.22M	$-13.77M	$-7.55M	$-14.66M	$-12.88M
High Forecast	$2.31M	$3.91M	$795.26K	$-118.46K	$-6.23M	$-7.19M	$-10.47M	$-12.43M	$-16.66M	$-13.85M	$-20.53M	$-21.71M	$-7.80M	$-14.26M	$-15.52M	$-19.82M	$-14.28M	$-14.14M	$-12.98M	$-9.01M	$-11.78M	$-15.19M	$-15.71M	$-10.12M	$-23.54M	$-2.22M	$-13.77M	$-6.04M	$-14.66M	$-12.88M
Low Forecast	$2.31M	$3.91M	$795.26K	$-118.46K	$-6.23M	$-7.19M	$-10.47M	$-12.43M	$-16.66M	$-22.31M	$-20.53M	$-21.71M	$-34.33M	$-14.26M	$-15.52M	$-19.82M	$-14.28M	$-14.14M	$-12.98M	$-13.51M	$-11.78M	$-15.19M	$-15.71M	$-15.17M	$-23.54M	$-2.22M	$-13.77M	$-9.06M	$-14.66M	$-12.88M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.40%	-2.15%	1.63%	1.33%	1.57%	4.94%	0.02%	1.63%	0.07%	1.16%	0.67%	1.43%	0.62%	5.50%	-0.16%	1.60%	0.52%	0.49%

Aemetis's average Quarter net income forecast for Dec 23 is $-18.20M, with a range of $-34.33M to $-7.80M. AMTX's average Quarter net income forecast represents a -159.27% decrease compared to the company's last Quarter net income of $30.71M (Sep 23).

Aemetis SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	1	2	4	2	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	5	5
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$9.79M	$8.98M	$9.71M	$10.79M	$7.52M	$6.87M	$7.06M	$7.31M	$7.45M	$5.09M	$5.75M	$5.38M	$4.33M	$4.56M	$4.05M	$3.94M	$4.71M	$4.53M
Avg Forecast	$26.36M	$25.04M	$22.40M	$22.12M	$15.08M	$13.24M	$11.39M	$11.28M	$10.45M	$9.51M	$9.18M	$9.61M	$9.29M	$9.39M	$6.39M	$7.41M	$8.89M	$8.39M	$7.37M	$4.50M	$7.09M	$6.75M	$6.75M	$3.76M	$6.09M	$7.43M	$6.06M	$2.46M	$5.82M	$5.97M
High Forecast	$26.36M	$25.04M	$22.40M	$22.12M	$15.08M	$13.24M	$11.39M	$11.28M	$10.45M	$10.58M	$9.18M	$9.61M	$12.29M	$9.40M	$6.39M	$7.41M	$8.89M	$8.39M	$7.37M	$5.40M	$7.09M	$6.75M	$6.75M	$4.51M	$6.09M	$7.43M	$6.06M	$2.96M	$5.82M	$5.97M
Low Forecast	$26.36M	$25.04M	$22.40M	$22.12M	$15.08M	$13.24M	$11.39M	$11.28M	$10.45M	$8.65M	$9.18M	$9.61M	$6.53M	$9.39M	$6.39M	$7.41M	$8.89M	$8.39M	$7.37M	$3.60M	$7.09M	$6.75M	$6.75M	$3.01M	$6.09M	$7.43M	$6.06M	$1.97M	$5.82M	$5.97M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.05%	0.96%	1.52%	1.46%	0.85%	0.82%	0.96%	1.63%	1.05%	0.75%	0.85%	1.43%	0.71%	0.61%	0.67%	1.60%	0.81%	0.76%

Aemetis's average Quarter SG&A projection for Mar 24 is $9.61M, based on 4 Wall Street analysts, with a range of $9.61M to $9.61M. The forecast indicates a -1.83% fall compared to AMTX last annual SG&A of $9.79M (Dec 23).

Aemetis EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	1	2	4	2	4	5	4	4	4	3	3	3	3	4	4	4	4	9	9	9	9	5	5
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.64	$0.79	$-0.68	$-0.73	$-0.63	$-2.01	$-0.01	$-0.54	$-0.03	$-0.79	$-0.30	$-0.69	$-0.67	$-0.99	$0.11	$-0.58	$-0.37	$-0.31
Avg Forecast	$0.05	$0.08	$0.02	$-0.00	$-0.13	$-0.15	$-0.22	$-0.26	$-0.35	$-0.38	$-0.43	$-0.46	$-0.39	$-0.30	$-0.33	$-0.42	$-0.30	$-0.32	$-0.29	$-0.31	$-0.27	$-0.34	$-0.35	$-0.53	$-0.53	$-0.05	$-0.31	$-0.34	$-0.33	$-0.29
High Forecast	$0.05	$0.08	$0.02	$-0.00	$-0.13	$-0.15	$-0.22	$-0.26	$-0.35	$-0.29	$-0.43	$-0.46	$-0.17	$-0.30	$-0.33	$-0.42	$-0.30	$-0.32	$-0.29	$-0.31	$-0.27	$-0.34	$-0.35	$-0.53	$-0.53	$-0.05	$-0.31	$-0.34	$-0.33	$-0.29
Low Forecast	$0.05	$0.08	$0.02	$-0.00	$-0.13	$-0.15	$-0.22	$-0.26	$-0.35	$-0.47	$-0.43	$-0.46	$-0.73	$-0.30	$-0.33	$-0.42	$-0.30	$-0.32	$-0.29	$-0.31	$-0.27	$-0.34	$-0.35	$-0.53	$-0.53	$-0.05	$-0.31	$-0.34	$-0.33	$-0.29
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.66%	-2.62%	2.07%	1.74%	2.08%	6.31%	0.02%	1.73%	0.10%	2.31%	0.85%	1.30%	1.26%	19.80%	-0.35%	1.71%	1.12%	1.07%

According to 5 Wall Street analysts, Aemetis's projected average Quarter EPS for Dec 23 is $-0.39, with a low estimate of $-0.73 and a high estimate of $-0.17. This represents a -148.80% decrease compared to AMTX previous annual EPS of $0.79 (Sep 23).

Aemetis Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
VTNR	Vertex Energy	$0.05	$9.60	19100.00%	Hold
CLNE	Clean Energy Fuels	$2.80	$5.00	78.57%	Strong Buy
DINO	HF Sinclair	$42.42	$57.50	35.55%	Buy
PARR	Par Pacific	$17.31	$23.33	34.78%	Hold
PBF	PBF Energy	$30.34	$39.92	31.58%	Buy
DK	Delek US	$18.96	$22.00	16.03%	Hold
SUN	Sunoco LP	$51.47	$54.60	6.08%	Buy
VLO	Valero Energy	$139.56	$145.47	4.23%	Buy
MPC	Marathon Petroleum	$159.11	$163.44	2.72%	Buy
PSX	Phillips 66	$129.91	$127.30	-2.01%	Buy
CVI	CVR Energy	$18.79	$17.67	-5.96%	Buy
AMTX	Aemetis	$4.13	$3.88	-6.05%	Buy

AMTX Forecast FAQ

Is Aemetis a good buy?

Yes, according to 9 Wall Street analysts, Aemetis (AMTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of AMTX's total ratings.

What is AMTX's price target?

Aemetis (AMTX) average price target is $3.88 with a range of $3.5 to $4.25, implying a -6.05% from its last price of $4.13. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Aemetis stock go up soon?

According to Wall Street analysts' prediction for AMTX stock, the company can go down by -6.05% (from the last price of $4.13 to the average price target of $3.88), up by 2.91% based on the highest stock price target, and down by -15.25% based on the lowest stock price target.

Can Aemetis stock reach $6?

AMTX's average twelve months analyst stock price target of $3.88 does not support the claim that Aemetis can reach $6 in the near future.

What are Aemetis's analysts' financial forecasts?

Aemetis's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $409.76M (high $409.76M, low $409.76M), average EBITDA is $-30.559M (high $-30.559M, low $-30.559M), average net income is $-36.327M (high $-36.327M, low $-36.327M), average SG&A $50.98M (high $50.98M, low $50.98M), and average EPS is $-0.769 (high $-0.769, low $-0.769). AMTX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $770.96M (high $770.96M, low $770.96M), average EBITDA is $-57.497M (high $-57.497M, low $-57.497M), average net income is $6.9M (high $6.9M, low $6.9M), average SG&A $95.92M (high $95.92M, low $95.92M), and average EPS is $0.146 (high $0.146, low $0.146).

Did the AMTX's actual financial results beat the analysts' financial forecasts?

Based on Aemetis's last annual report (Dec 2023), the company's revenue was $186.72M, which missed the average analysts forecast of $261.05M by -28.47%. Apple's EBITDA was $-30.396M, beating the average prediction of $-19.468M by 56.13%. The company's net income was $-46.42M, missing the average estimation of $-67.804M by -31.54%. Apple's SG&A was $39.27M, beating the average forecast of $32.48M by 20.90%. Lastly, the company's EPS was $-1.22, missing the average prediction of $-1.436 by -15.04%. In terms of the last quarterly report (Dec 2023), Aemetis's revenue was $70.76M, missing the average analysts' forecast of $74.65M by -5.21%. The company's EBITDA was $-7.198M, beating the average prediction of $-5.567M by 29.29%. Aemetis's net income was $-25.442M, beating the average estimation of $-18.204M by 39.76%. The company's SG&A was $9.79M, beating the average forecast of $9.29M by 5.37%. Lastly, the company's EPS was $-0.64, beating the average prediction of $-0.386 by 66.00%